Black Ant — Class I drug recall D-1224-2014
Terminated recall by American Lifestyle.Com, reported 2014-04-16. Marketed without an Approved NDA/ANDA: Laboratory analysis conducted by the FDA has determined the Vicerex pro
| Recall number | D-1224-2014 |
|---|---|
| Product type | Drug |
| Classification | Class I |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | American Lifestyle.Com, Pittsford, NY, United States |
| Recall initiated | 2013-04-30 |
| Classified | 2014-04-07 |
| Reported by FDA | 2014-04-16 |
| Terminated | 2018-06-27 |
| Countries outside the US | BE, BR, CA, CH, DK, ES, FR, IE, IT, JP, MX, OM, VE |
| Reason classes | undeclared allergen, unapproved product |
| UPC / GTIN / UDI-DI | 04026666142546 |
Product
Black Ant, 4600 mg x 4. Product is packaged in a small green box with gold lettering on the front, the back side of the box contains mostly foreign character. Within the box there are four (4) capsules individually wrapped in black and red plastic with white lettering. UPC 4026666142546 (product numbers may possibly vary for same product identification and same product packaging).
Reason for recall
Marketed without an Approved NDA/ANDA: Laboratory analysis conducted by the FDA has determined the Vicerex product contains undeclared tadalafil and the Black Ant product contains undeclared sildenafil. Tadalafil and sildenafil are FDA-Approved drugs used to treat male erectile dysfunction (ED), making the Vicerex and the Black Ant products unapproved new drugs.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1224-2014. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.